Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
a16x7rHPwuaep5aq
Listen
